MUST Beg to Differ.

Journal Article (Editorial)

The authors provide a significant interpretation of the National Eye Institute-sponsored Multicenter Uveitis Steroid Treatment study, in which patients with severe, non-infectious intermediate, posterior, or panuveitis were randomly assigned to receive local treatment using the sutured intravitreal fluocinolone acetonide implant or systemic treatment consisting of oral steroids and conventional steroid-sparing immunosuppression, with a primary outcome of visual acuity at 2 years of follow-up. The authors also present evidence-based guidance for the treatment of noninfectious posterior segment involving uveitis. [Ophthalmic Surg Lasers Imaging Retina. 2019;50:266-268.].

Full Text

Duke Authors

Cited Authors

  • Albini, T; Callaway, NF; Jaffe, GJ; Feuer, W; Davis, J; Goldstein, D; Lowder, C; Lin, P; Nguyen, Q; Srivastava, S; Callanan, D; Galor, A; Goldhardt, R; Flynn, H

Published Date

  • May 1, 2019

Published In

Volume / Issue

  • 50 / 5

Start / End Page

  • 266 - 268

PubMed ID

  • 31100155

Electronic International Standard Serial Number (EISSN)

  • 2325-8179

Digital Object Identifier (DOI)

  • 10.3928/23258160-20190503-01


  • eng

Conference Location

  • United States